You are viewing: North America Respiratory Care Devices Market analysis

The North America Respiratory Care Devices Market was valued at $61.4 Million in 2025 and projected to reach to $86.2 Million by 2030, representing a compound annual growth rate of 7.0%. North America's respiratory care devices market is positioned for sustained growth through 2030, driven by an aging population with chronic respiratory diseases and increasing neonatal care investments.

North America Respiratory Care Devices Market Trends and Insights

  • Oxygen Hoods are specialized delivery systems designed to provide controlled oxygen therapy, particularly in neonatal and pediatric care settings.
  • The segment's steady 7.0% compound annual growth rate reflects increasing demand for non-invasive respiratory support solutions and rising awareness of oxygen therapy efficacy in clinical environments. The expansion of Oxygen Hoods is driven by advancements in device design, growing prevalence of respiratory conditions, and enhanced healthcare infrastructure in emerging markets.
  • Oxygen Hoods continue to gain adoption due to their ease of use, patient comfort, and effectiveness in delivering precise oxygen concentrations.
  • Between 2025 and 2030, Oxygen Hoods are expected to capture greater market share as healthcare providers prioritize safer, more efficient respiratory care alternatives. Oxygen Hoods maintain competitive positioning through continuous innovation and regulatory compliance.
  • The segment's growth trajectory underscores the importance of reliable oxygen delivery mechanisms in modern clinical practice, with Oxygen Hoods serving as a cornerstone technology for respiratory care protocols globally..

Key Market Statistics

  • CAGR (2025-2030) 7.0% CAGR
  • Market Size, 2025 ~USD 61.4 Million
  • Forecast, 2030 ~USD 86.2 Million
  • Geography North America

North America Respiratory Care Devices Market Overview

Strong US Market Dominance :

The United States commands the North American respiratory care devices market with a valuation of $13.4 billion, representing over 95% of the region's total market share and driving innovation in oxygen delivery systems.

Steady Regional Growth Trajectory :

North America's 7.0% CAGR through 2030 is supported by aging demographics, increased prevalence of respiratory conditions, and advanced healthcare infrastructure across the US and Canada.

Neonatal Care Expansion :

Growing investment in neonatal intensive care units (NICUs) and pediatric respiratory therapy across North American hospitals is driving demand for specialized oxygen delivery systems like oxygen hoods.

Regulatory Excellence & Reimbursement :

Favorable FDA approval pathways and comprehensive insurance coverage for respiratory care devices in the US and Canada create a stable market environment for device manufacturers and healthcare providers.

North America Respiratory Care Devices Market Dynamics

  • The region benefits from advanced healthcare infrastructure, strong reimbursement policies, and continuous technological innovation in oxygen delivery systems.
  • The US market's dominance is complemented by Canada's growing healthcare expenditures, creating a robust market for specialized respiratory solutions.
  • Regulatory support and clinical adoption of advanced oxygen hoods in pediatric settings will further accelerate market expansion..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • Oxygen Hoods market is valued at $61.4 million in 2025 and projected to reach $86.2 million by 2030, representing a 7.0% CAGR.
    • Oxygen Hoods are increasingly preferred for neonatal and pediatric respiratory care due to non-invasive delivery and improved patient outcomes.
    • Technological innovations in Oxygen Hoods design enhance oxygen delivery precision and user convenience, driving market adoption.
    • Oxygen Hoods benefit from expanding healthcare infrastructure and rising respiratory disease prevalence in developing regions.

    Respiratory Care Devices Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment HOME CARE SETTINGS (End User)
    Forecast Period 2025–2030
    Growth Rate CAGR of 7.3% from 2025 to 2030
    Largest Segment HOSPITALS (End User)
    Market Size Base Year (Billions) ~USD 23.62 (2025)
    Revenue Forecast (Billions) ~USD 33.6 (2030)
    Segments Covered Product, Type, Disease Indication, End User

    North America Respiratory Care Devices Market Report Segmentation

    4 segment dimensions are covered across the global market.

    By Product

    • Consumables & Accessories
    • Diagnostic Respiratory Care Devices
    • Monitoring Devices
    • Pulse Oximeter Equipment
    • Pulse Oximeter Sensors
    • Therapeutic Respiratory Care Devices

    By Type

    • Apap Devices
    • Basic Ventilators
    • Bipap Devices
    • Breathing Circuits
    • Capnographs
    • Cpap Devices
    • Disposable Masks
    • Disposable Resuscitators
    • Dry Powder Inhalers (Dpis)
    • Fixed Oxygen Concentrators
    • Gas Analyzers
    • Heated Humidifiers
    • High-End Ventilators
    • Humidifiers
    • Icu Ventilators
    • Inhalers
    • Jet Nebulizers
    • Masks
    • Mesh Nebulizers
    • Metered-Dose Inhalers (Mdis)
    • Mid-End Ventilators
    • Nasal Cannulae
    • Nebulizers
    • Nitric Oxide Delivery Units
    • Other Consumables & Accessories
    • Other Diagnostic Devices
    • Oxygen Concentrators
    • Oxygen Hoods
    • Pap Devices
    • Passover Humidifiers
    • Peak Flow Meters
    • Polysomnography Devices (Psg Devices)
    • Portable Oxygen Concentrators
    • Portable/Transportable Ventilators
    • Pulse Oximeter Equipment
    • Pulse Oximeter Sensors
    • Pulse Oximeters
    • Reusable Masks
    • Reusable Resuscitators
    • Spirometers
    • Tracheostomy Tubes
    • Ultrasonic Nebulizers
    • Ventilators

    By Disease Indication

    • Asthma
    • Chronic Obstructive Pulmonary Disease (Copd)
    • Infectious Diseases
    • Other Disease Indications
    • Sleep Apnea

    By End User

    • Ambulatory Care Centers (Accs)
    • Home Care Settings
    • Hospitals
    • Other End Users

    Target Audience

    • Medical Device Manufacturers : Manufacturers need North America-specific market data to develop region-tailored respiratory care products, optimize pricing strategies, and identify neonatal care opportunities in the US and Canada.
    • Healthcare Providers & Hospitals : Hospital administrators and procurement teams require market insights to budget for respiratory care equipment, evaluate supplier options, and plan NICU expansions across North America.
    • Investment & Private Equity Firms : Investors analyzing respiratory care device companies need North American market forecasts and growth drivers to assess portfolio opportunities and valuation multiples in this high-growth segment.
    • Healthcare Consultants : Consulting firms advising healthcare systems and device manufacturers require detailed North American market data to develop go-to-market strategies and competitive positioning recommendations.
    • Regulatory & Compliance Officers : Compliance professionals need region-specific market intelligence to understand FDA requirements, reimbursement policies, and competitive standards for respiratory devices in North America.

    Key Companies in the North America Respiratory Care Devices Market

    CompanyHQOwnershipStrongest segments
    ASTRAZENECAUnited KingdomPublic CompanyOncology,Cardiovascular, Renal and Metabolism (CVRM),Respiratory & Immunology,
    KINDRED HEALTHCARE INC.United StatesPrivate CompanyInjectable and infusion-based delivery (IV, subcutaneous, ports, pumps),Oral solid and liquid regimens (chronic disease management),Topical, transdermal, and local delivery,
    DENTSPLY SIRONAUnited StatesPublic CompanyConnected Technology Solutions (imaging, CEREC, digital hardware),Essential Dental Solutions (endodontics, restorative, preventive consumables),Orthodontic and Implant Solutions (SureSmile, implants, digital dentures),
    AMBUDenmarkPublic CompanyEndoscopy (single-use and related systems),Airway Management and Anaesthesia,Neurology (EEG/EMG and IOM),
    APTARGROUP INCUnited StatesPublic CompanyPharma,Beauty,Closures,
    CONMED CORPORATIONUnited StatesPublic CompanyOrthopedic and sports medicine (BioBrace, TruShot, Y-Knot, Hall power tools),General surgery (AirSeal, Buffalo Filter, endomechanical, electrosurgery),Endoscopic technologies (GI therapeutics and diagnostics),
    CONSORT MEDICALUnited KingdomPrivate CompanyInhalation devices (MDIs, DPIs, soft-mist),Injectable and autoinjector platforms,Nasal and other specialty delivery devices,
    CONVATECUnited KingdomPublic CompanyAdvanced wound care,Ostomy care,Continence and critical care,
    HENRY SCHEINUnited StatesPublic CompanyGlobal Distribution and Value-Added Services,Global Specialty Products,Global Technology,
    ROSSMAX INTERNATIONAL LTDTaiwanPublic CompanyBlood pressure monitors & sphygmomanometers,Thermometers (including non-contact telephoto),Respiratory care (nebulizers, suction units, aero spacers, peak flow meters),
    THE TIMKENUnited StatesPublic CompanyEngineered Bearings,Industrial Motion,
    KONINKLIJKE PHILIPS N.V.NetherlandsPublic CompanyDiagnosis & Treatment (Imaging and Image-Guided Therapy),Connected Care (Monitoring, Enterprise Informatics, Sleep and Respiratory Care),Personal Health,
    MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (including Diabetes),
    RESMED INC.United StatesPublic CompanySleep and Breathing Health devices (PAP, ventilators, diagnostics),Cloud platforms and patient apps (AirView, myAir, connectivity modules),Residential Care Software (Brightree, HEALTHCAREfirst, MatrixCare, MEDIFOX DAN),
    FISHER & PAYKEL HEALTHCARE LIMITEDNew ZealandPublic CompanyHospital respiratory and humidification systems (adult and infant),Homecare OSA and chronic respiratory (CPAP devices, masks, humidifiers),Surgical and perioperative products,
    DRäGERWERK AG & CO. KGAAGermanyPublic CompanyMedical ventilators, anaesthesia, and lung monitoring,Patient monitoring, neonatal care, and hospital infrastructure,Gas detection (fixed and portable),
    MASIMOUnited StatesPrivate CompanySET and Rainbow SET pulse oximetry and CO-oximetry,Brain function and hemodynamic monitoring, regional oximetry,Hospital automation and connectivity (Patient SafetyNet, Iris, iSirona, UniView, Replica),
    GETINGESwedenPublic CompanyAcute Care Therapies (ECMO, ventilation, monitoring, ICU infrastructure, drainage),Surgical Workflows (OR equipment, anesthesia, OR integration, sterile supply management),Life Science (biocontainment, sterilization, isolation, bioprocess, labware cleaning),
    NIHON KOHDEN CORPORATIONJapanPublic CompanyPatient monitors & clinical information systems,Physiological measuring equipment (EEG, ECG, EMG, cath lab polygraphs),Defibrillators, AEDs, ventilators, anesthesia and therapeutic devices,
    GE HEALTHCAREUnited StatesPublic CompanyImaging,Advanced Visualization Solutions (including Ultrasound and Interventional),Patient Care Solutions,
    ADAPTHEALTH, LLCUnited StatesPublic CompanySleep Health (PAP machines, supplies, OSA services),Respiratory Health (oxygen, ventilation, chronic therapy),Diabetes Health (CGMs, insulin pumps, supplies),
    TELEFLEX INCORPORATEDUnited StatesPublic CompanyVascular access & emergency medicine (Arrow, EZ-IO, FAST1, QuikClot),Surgical products (Weck, MiniLap, Pleur-Evac, Deknatel, KMedic, Pilling, Titan SGS),Interventional cardiology and peripheral (GuideLiner, Turnpike, TrapLiner, MANTA, DCBs, stents),
    AIR LIQUIDEFrancePublic CompanyLarge Industries (oxygen, nitrogen, argon, hydrogen, CO, cogeneration),Industrial Merchant (packaged and bulk gases, equipment, hardgoods, services),Healthcare (medical gases, home healthcare, specialty ingredients, equipment),
    ICU MEDICAL, INC.United StatesPublic CompanyInfusion therapy & IV solutions,Vascular access & needlefree connectors,Infusion pumps & medication safety software,

    ASTRAZENECA

    AstraZeneca is a United Kingdom-based pharmaceutical company founded in 1992 that operates as a public company with 96,100 employees.

    KINDRED HEALTHCARE INC.

    Kindred Healthcare Inc. is a United States-based private company founded in 1985 with 64,200 employees.

    DENTSPLY SIRONA

    Dentsply Sirona is a United States-based public company founded in 1877 with 14,000 employees, operating in the dental and oral healthcare sector.

    AMBU

    Ambu is a Denmark-based public company founded in 1937 with 5,200 employees.

    APTARGROUP INC

    Aptar Group Inc. is a United States-based public company founded in 1992 with 14,000 employees.

    CONMED CORPORATION

    ConMed Corporation is a United States-based public company founded in 1970 with 3,900 employees.

    CONSORT MEDICAL

    Consort Medical is a United Kingdom-based private company founded in 1938 with 2,000 employees.

    CONVATEC

    ConvaTec is a United Kingdom-based public company founded in 1978.

    HENRY SCHEIN

    Henry Schein is a United States-based public company founded in 1932 with 25,000 employees.

    ROSSMAX INTERNATIONAL LTD

    Rossmax International Ltd. is a Taiwan-based public company founded in 1988.

    THE TIMKEN

    The Timken Company is a United States-based public company founded in 1899 with 19,000 employees.

    KONINKLIJKE PHILIPS N.V.

    Koninklijke Philips N.V. is a Netherlands-based public company founded in 1891 with 64,317 employees.

    MEDTRONIC

    Medtronic is an Ireland-based public company founded in 1949 with 95,000 employees.

    RESMED INC.

    ResMed Inc. is a United States-based public company founded in 1989 with 10,600 employees.

    FISHER & PAYKEL HEALTHCARE LIMITED

    Fisher & Paykel Healthcare Limited is a New Zealand-based public company founded in 1934 with 7,396 employees.

    DRäGERWERK AG & CO. KGAA

    Drägerwerk AG & Co. KGaA is a Germany-based public company founded in 1889 with 16,033 employees.

    MASIMO

    Masimo is a United States-based private company founded in 1989 with 2,200 employees.

    GETINGE

    Getinge is a Sweden-based public company founded in 1904 with 11,754 employees.

    NIHON KOHDEN CORPORATION

    Nihon Kohden Corporation is a Japan-based public company founded in 1951 with 6,116 employees.

    GE HEALTHCARE

    GE Healthcare is a United States-based public company founded in 2022 with 54,000 employees.

    ADAPTHEALTH, LLC

    AdaptHealth, LLC is a United States-based public company founded in 2012 with 10,900 employees.

    TELEFLEX INCORPORATED

    Teleflex Incorporated is a United States-based public company founded in 1943 with 15,500 employees.

    AIR LIQUIDE

    Air Liquide is a France-based public company founded in 1902 with 63,126 employees.

    ICU MEDICAL, INC.

    ICU Medical, Inc. is a United States-based public company founded in 1984 with 13,000 employees.

    North America vs. other regions

    HowNorth America compares to the other 3 regional blocs covered in this market.

    Global
    ~USD 1689.6 Million · 6.1% wtd CAGR ·
    Europe
    ~USD 4940.3 Million · 6.3% wtd CAGR ·
    Asia Pacific
    ~USD 2913.3 Million · 4.1% wtd CAGR ·

    Countries within North America - compare and drill down

    Country2025 size (native)
    USUSD 13422 Million
    CanadaUSD 692.1 Million

    Country market size visualization

    US
    USD 13422 Million
    Canada
    USD 692.1 Million

    Reasons to Buy this Report

    • Market Size & Growth Data : Access precise valuation of North America's respiratory care market at $61.4M (2025) with 7% CAGR projections through 2030, enabling accurate financial forecasting and investment decisions.
    • Country-Level Breakdown : Detailed market segmentation for the US ($13.4B) and Canada ($692.1M) provides granular insights for regional expansion strategies and competitive positioning.
    • Neonatal Segment Intelligence : Specialized analysis of oxygen hoods and pediatric respiratory devices reveals high-growth opportunities in NICU settings across North American healthcare facilities.
    • Regulatory & Reimbursement Landscape : Comprehensive understanding of FDA approval processes and insurance coverage frameworks in the US and Canada informs product development and market entry strategies.
    • Competitive Benchmarking : Compare your organization's performance against North American market trends and identify gaps in the oxygen delivery device segment for strategic advantage.

    Frequently asked questions

    What is the market size of Oxygen Hoods in 2025?

    Oxygen Hoods market is estimated at $61.4 million in 2025, with verified data from market analysis.

    What is the projected market size for Oxygen Hoods by 2030?

    Oxygen Hoods are forecast to reach $86.2 million by 2030, reflecting sustained market growth.

    What is the CAGR for Oxygen Hoods?

    Oxygen Hoods demonstrate a compound annual growth rate of 7.0% from 2025 to 2030.

    Which patient populations benefit most from Oxygen Hoods?

    Oxygen Hoods are primarily utilized in neonatal and pediatric care settings where non-invasive oxygen delivery is critical.

    What factors drive growth in the Oxygen Hoods market?

    Oxygen Hoods growth is driven by technological innovation, rising respiratory disease prevalence, and expanding healthcare infrastructure globally.

    RESEARCH METHODOLOGY

    This study involved four major activities in estimating the current respiratory care devices market size. First, extensive secondary research was conducted to gather information on the market, including related and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

    Secondary Research

    The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the respiratory care devices market. It was also used to obtain important information about the key players and market classification and segmentation according to industry trends to the bottom-most level, as well as key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations operating in the respiratory care devices market. The primary sources from the demand side included industry experts, purchase & sales managers, doctors, and personnel from research organizations. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends and key market dynamics.

    A breakdown of the primary respondents for the respiratory care devices market is provided below:

    Respiratory Care Devices Market

    Note 1: C-level primaries include CEOs, CFOs, COOs, and VPs.

    Note 2: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

    Note 3: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion.

    Source: MarketsandMarkets Analysis

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global respiratory care devices market. All the major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players. Also, the global respiratory care devices market was split into various segments and subsegments based on:

    • List of major players operating in the products market at the regional and/or country level
    • Product mapping of various respiratory care device manufacturers at the regional and/or country level
    • Mapping of annual revenue generated by listed major players from respiratory care devices (or the nearest reported business unit/product category)
    • Revenue mapping of major players to covered
    • Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
    • Summation of the market value of all segments/subsegments to arrive at the global market

    The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

    Bottom-up Approach and Top-down Approach

    Respiratory Care Devices Market

    Data Triangulation

    After arriving at the overall size of the global respiratory care devices market through the above-mentioned methodology, this market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.

    Market Definition

    Respiratory care is a healthcare specialty that provides diagnostic evaluation, management, control, therapy, and monitoring of cardiopulmonary system diseases and disorders. Respiratory care devices are extensively used in general & surgical wards and ICUs as a life support measure.

    Stakeholders

    • Respiratory Care Device Manufacturers and Distributors
    • Healthcare Institutions (Hospitals, Laboratories, Medical Schools, and Outpatient Clinics)
    • Research Institutes
    • Contract Manufacturing Organizations (CMOs)
    • Government Associations
    • Market Research and Consulting Firms
    • Venture Capitalists and Investors

    Report Objectives

    • To define, describe, and forecast the respiratory care devices market based on product type, disease indication, end user, and region
    • To forecast the market size based on five key regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
    • To strategically analyze the industry trends, technology trends, pricing analysis, regulatory scenario, supply/value chain, ecosystem mapping, Porter’s Five Forces, patent analysis, key stakeholders and buying criteria, and conferences & events
    • To provide detailed information regarding the major factors influencing the growth of this market (such as drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall respiratory care devices market
    • To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
    • To strategically profile key players in the respiratory care devices market and comprehensively analyze their core competencies
    • To track and analyze competitive developments such as product launches & approvals, partnerships, agreements, collaborations, joint ventures, expansions, and acquisitions in the overall respiratory care devices market
    • To benchmark players within the market using the proprietary “Competitive Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product/service strategy
    • To analyze the generative AI impact on the respiratory care devices market

     

    Get the Full Respiratory Care Devices Market Report

    Full forecast, segment splits, and company analysis for all Respiratory Care Devices Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status